선택적 제품 분석
허용하는 경우 개인정보 보호를 고려한 제한적 분석을 사용해 어떤 리서치 여정이 효과적인지 파악합니다. 광고 추적기나 세션 녹화는 사용하지 않습니다. 환경설정에서 이 선택을 변경할 수 있습니다. 자세한 내용은 개인정보 처리방침.
Northrop Grumman Corporation's published Hold conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $76.6B | |
|---|---|---|
| Revenue (ttm) | 43.6B | |
| Net income (ttm) | 4.5B | |
| EPS (ttm) | $31.7 | |
| Shares out | 142.1M | |
| P/E (trailing) | 17.4x | |
| P/E (forward) | 17.0x | |
| Dividend | $9.88 (1.79%) | |
| Volume | 554,503 | |
| Beta | -0.11 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $35.67B | $36.60B | $39.29B | $41.03B | $41.95B | +4.1% |
| Gross profit | $7.27B | $7.47B | $39.29B | $8.36B | $8.31B | +3.4% |
| Operating income | $5.65B | $3.60B | $2.54B | $4.37B | $4.51B | -5.5% |
| Net income | $7.01B | $4.90B | $2.06B | $4.17B | $4.18B | -12.1% |
| EPS (diluted) | $43.54 | $31.47 | $13.53 | $28.34 | $29.08 | -9.6% |
| EBITDA | $8.73B | $7.68B | $2.54B | $6.84B | $7.21B | -4.7% |
| R&D | $1.10B | $1.20B | $1.20B | $1.10B | $1.10B | +0.0% |
| SG&A | $3.60B | $3.87B | $4.01B | $3.99B | $4.03B | +2.9% |
Recent company headlines from major financial publishers.
Accelerated transition from low-rate initial production to full-rate production across the B-21 Raider bomber and Sentinel ICBM programs expands segment operating margins toward 12.0%, while international allied defense demand drives sales growth at the upper bound of 7.0%, supporting an 8.5% annual EPS growth path and lifting intrinsic value toward $820.75.
Northrop Grumman executes steadily against its $109.6 billion backlog, achieving full-year 2026 sales of $43.75B-$44.25B and 2027 top-line growth of 5% to 7%. Segment operating margins expand moderately from 11.3% in 2026 to 11.4%-11.6% by 2030, absorbing the $2.1 billion capex ramp in 2027 while adjusted free cash flow expands from $3.1B-$3.5B to $3.3B-$3.7B. Discounted at a 6.68% cost of equity, this yields a central fair value of $574.82 per share.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 5.7% | $622 | $640 | $659 | $683 | $710 |
| 6.2% | $584 | $597 | $612 | $629 | $648 |
| 6.7% | $554 | $564 | $575 | $587 | $602 |
| 7.2% | $528 | $536 | $545 | $555 | $566 |
| 7.7% | $507 | $513 | $520 | $528 | $536 |
Upcoming earnings date and setup when available.
매월 발행된 리서치 판이 부여한 등급입니다. 등급은 분석 시점의 가격을 공정 가치와 비교한 것이며, 판단이 맞았는지에 대한 기록이 아닙니다.
| 연도 | 1월 | 2월 | 3월 | 4월 | 5월 | 6월 | 7월 | 8월 | 9월 | 10월 | 11월 | 12월 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |